搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
openaccessgovernment
2 小时
Early intervention for eating disorders
Tracey Wade provides an insightful examination of the significance of brief early interventions in the treatment of eating ...
AlphaGalileo
3 小时
Patients taking edoxoban after heart valve surgery had lower risk of stroke, blood clots
Patients who receive a heart valve replacement are well-known to be at a high risk for stroke, blood clots and deep vein ...
4 小时
on MSN
Galaxy health insurance offers extensive benefits for surrogacy and fertility treatments ...
A comprehensive health insurance plan that covers the entire gamut of treatments is something that customers look forward to ...
AlphaGalileo
4 小时
Blood thinners didn’t reduce cognitive decline in adults 65 and younger with AFib
AFib is the most common type of irregular heart rhythm in the U.S., and blood thinners, also known as anti-clotting ...
healthcare-in-europe.com
12 小时
CE Mark for new GI motility testing system
It can measure and display diameter estimates at up to 16 points within the balloon while also displaying balloon pressure.
20 小时
on MSN
ALUT and OTI plan fundraiser to help Israelis on autism spectrum
The fundraising day will focus on the struggle to preserve the daily routine and activities of children and adults with ...
ConsumerAffairs
2 天
What are ADHD rating scales?
An ADHD rating scale is an umbrella term for tools used to help patients, families, educators and clinicians assess and ...
verywellhealth
2 天
4 Proven Ways to Tackle Seasonal Affective Disorder, According to Experts
Seasonal Affective Disorder (SAD) affects millions of Americans, and cases usually start to rise in late fall or early winter ...
2 天
Mouth cancer cases hit new record in England and Scotland – what you need to know
Cases of mouth cancer have reached a record high in England and Scotland, a new report shows. Last year, there were more than ...
TMCnet
2 天
InflaRx Receives Positive CHMP Opinion for GOHIBIC® (Vilobelimab) for the Treatment of ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...
3 天
Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic ...
Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.
3 天
Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic ...
Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈